Viewing Study NCT00035334


Ignite Creation Date: 2025-12-25 @ 2:19 AM
Ignite Modification Date: 2025-12-26 @ 6:13 PM
Study NCT ID: NCT00035334
Status: COMPLETED
Last Update Posted: 2006-02-14
First Post: 2002-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
Sponsor: Bellus Health Inc. - a GSK company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module